Image showing sections of cerebral brain organoids derived from pluripotent stem cells.
via Agnieszka Rybak-Wolf, MDC/LifeTime
Hundreds of researchers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare. In a perspective in Nature and the LifeTime Strategic Research Agenda they now present a roadmap of how to leverage the latest scientific breakthroughs and technologies over the next decade, to track, understand and treat human cells throughout an individual’s lifetime.
The LifeTime initiative, co-coordinated by the Max Delbrück Center of Molecular Medicine in the Helmholtz Association (MDC) in Berlin and the Institut Curie in Paris, has developed a strategy to advance personalized treatment for five major disease classes: cancer, neurological, infectious, chronic inflammatory and cardiovascular diseases. The aim is a new age of personalized, cell-based interceptive medicine for Europe with the potential of improved health outcomes and more cost-effective treatment, resulting in profoundly changing a person’s healthcare experience.
Earlier detection and more effective treatment of diseases
To form a functioning, healthy body, our cells follow developmental paths during which they acquire specific roles in tissues and organs. But when they deviate from their healthy course, they accumulate changes leading to disease which remain undetected until symptoms appear. At this point, medical treatment is often invasive, expensive and inefficient. However, now we have the technologies to capture the molecular makeup of individual cells and to detect the emergence of disease or therapy resistance much earlier.
Using breakthrough single-cell and imaging technologies in combination with artificial intelligence and personalized disease models will allow us to not only predict disease onset earlier, but also to select the most effective therapies for individual patients. Targeting disease-causing cells to intercept disorders before irreparable damage occurs will substantially improve the outlook for many patients and has the potential of saving billions of Euros of disease-related costs in Europe.
A detailed roadmap for implementing LifeTime
The perspective article “The LifeTime initiative and the future of cell-based interceptive medicine in Europe” and the LifeTime Strategic Research Agenda (SRA) explain how these technologies should be rapidly co-developed, transitioned into clinical settings and applied to the five major disease areas. Close interactions between European infrastructures, research institutions, hospitals and industry will be essential to generate, share and analyze LifeTime’s big medical data across European borders. The initiative’s vision advocates ethically responsible research to benefit citizens all across Europe.
According to Professor Nikolaus Rajewsky, scientific director of the Berlin Institute for Medical System Biology at the Max Delbrück Center for Molecular Medicine and coordinator of the LifeTime Initiative, the LifeTime approach is the way into the future: “LifeTime has brought together scientists across fields – from biologists, to clinicians, data scientists, engineers, mathematicians, and physicists – to enable a much improved understanding of molecular mechanisms driving health and disease. Cell-based medicine will allow doctors to diagnose diseases earlier and intercept disorders before irreparable damage has occurred. LifeTime has a unique value proposition that promises to improve the European patient’s health.”
Dr. Geneviève Almouzni, director of research at CNRS, honorary director of the research center from Institut Curie in Paris and co-coordinator of the LifeTime Initiative believes that the future with LifeTime offers major social and economic impact: “By implementing interceptive, cell-based medicine we will be able to considerably improve treatment across many diseases. Patients all over the world will be able to lead longer, healthier lives. The economic impact could be tremendous with billions of Euros saved from productivity gains simply for cancer, and significantly shortened ICU stays for Covid-19. We hope EU leaders will realize we have to invest in the necessary research now.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cell-based interceptive medicine
- Stem Cells News
Genetically Modified Pluripotent Stem Cells May Evade Immunological Rejection After Transplantation, Study Shows Jan. 11, 2024 — One of the biggest barriers to regenerative medicine is ...
- New technique improves T cell-based immunotherapies for solid tumors
"Solid tumors form a microenvironment around themselves that is immunosuppressive," says senior author Peng Wu, Ph.D., a professor in the Department of Molecular Medicine at Scripps Research. "Immune ...
- Cytiva Introduces New Cell Manufacturing Lines for Viral Vectors
Stable cell lines can streamline the product manufacturing process by simplifying workflows and extensively reducing raw materials.
- Prime Medicine Gets FDA Okay for First Trial of Gene Editing Technique
The FDA has cleared a clinical trial of an ex vivo prime editing candidate in patients with a rare disease, Prime Medicine announced Monday. The technique taps CRISPR technology to rewrite defective ...
- Cancer cell–immune cell interactions can predict immunotherapy response
By examining which genes were turned on and off in a mix of cell types from breast cancer biopsies, a team led by UT Southwestern Medical Center researchers developed a tool that can accurately ...
Go deeper with Google Headlines on:
Cell-based interceptive medicine
[google_news title=”” keyword=”cell-based interceptive medicine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
LifeTime Initiative
- Celebrating Free Comic Book Day in SWFL
JP Sports store manager Jonathan Powell said this is a generational event that brings families together to reminisce on comics and other hobby-related knickknacks.
- "And the Lifetime Achievement in Healthcare at AHAS Summit goes to..."
Founder and medical director of Child Accra, Juliette Tuakli, has been awarded a lifetime achievement award at the fourth Africa Healthcare Awards and Summit (AHAS) for her tireless efforts and ...
- A New Wave of Appreciation for the Man Who Drew New York
Jason Polan chronicled city life in thousands of sketches before he died at 37 in 2020. What happens to his legacy now?
- O! Millionaire: A Green Initiative with Exciting Rewards
Introduction to O! MillionaireO! Millionaire is not merely a chance-based game but an engaging platform that combines the thrill of winning with environmental consciousness. It centers around the ...
- Nicole Brown Simpson Lifetime Doc Gets Premiere Date and Trailer: “Her Life Was Stolen From Her”
The two-night docuseries event will premiere in June and is part of the A+E Networks cable channel's Stop Violence Against Women initiative.
Go deeper with Google Headlines on:
LifeTime initiative
[google_news title=”” keyword=”LifeTime initiative” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]